Document
EMA's response to TB CAB letter regarding the filing of the drugs delamanid and bedaquiline for market approval.
Get document:
Download from this site |
Recommended citation: EMA's response to TB CAB letter regarding the filing of the drugs delamanid and bedaquiline for market approval.. http://www.tbonline.info/media//media/uploads/documents/response_to_tb_cab_on_delamanid_and_bedaquiline_march_2013.pdf
Description
Catalogue:
None